Jochen Schmitt

发表

After the approval of dupilumab for moderate‐to‐severe atopic dermatitis: what is next on the research agenda?

J. Schmitt, Jochen Schmitt, 2018, The British journal of dermatology.

EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference

J. Schmitt, P. Spuls, M. Leeflang, 2012, Allergy.

A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal

J. Schmitt, S. Weidinger, H. Baurecht, 2017, The British journal of dermatology.

Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment

J. Schmitt, B. Rzany, A. Nast, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficacy and safety of systemic treatments for moderate‐to‐severe psoriasis: meta‐analysis of randomized controlled trials

E. Haufe, J. Schmitt, A. Nast, 2014, The British journal of dermatology.

Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta‐analysis of randomized controlled trials

J. Schmitt, Å. Svensson, L. V. von Kobyletzki, 2011, The British journal of dermatology.

A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis

J. Schmitt, K. Kragballe, K. Reich, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany

H. Williams, J. Schmitt, H. Williams, 2010, The British journal of dermatology.

TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries

C. Flohr, P. Williamson, J. Schmitt, 2018, The British journal of dermatology.

Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population‐based sample

D. Ford, J. Schmitt, D. Ford, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

The European treatment of severe atopic eczema in children taskforce (TREAT) survey

C. Flohr, J. Schmitt, S. Ayis, 2012, The British journal of dermatology.

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany

K. Schäkel, E. Haufe, T. Bieber, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Increased attention‐deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use

F. Plessow, V. Roessner, J. Schmitt, 2018, Allergy.

Nonallergic comorbidities of atopic eczema: an overview of systematic reviews

J. Schmitt, S. Deckert, C. Kopkow, 2014, Allergy.

Occupational skin cancer induced by ultraviolet radiation and its prevention

T L Diepgen, H. Drexler, T. Diepgen, 2012, The British journal of dermatology.

Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer‐free individuals. A secondary data analysis

S. Singer, F. Trautmann, J. Schmitt, 2017, European journal of cancer care.

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema

L. Naldi, C. Flohr, J. Schmitt, 2019, The British journal of dermatology.

Altered hypothalamus-pituitary-adrenal axis function: A relevant factor in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder?

F. Plessow, V. Roessner, J. Schmitt, 2019, Psychoneuroendocrinology.

The European treatment of severe atopic eczema in children taskforce (TREAT) survey

C. Flohr, S. Ayis, K. Logan, 2013, The British journal of dermatology.

Which factors predict incident pressure ulcers in hospitalized patients? A prospective cohort study

M. Eberlein-Gonska, T. Petzold, Jochen Schmitt, 2014, The British journal of dermatology.

Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma

C. Günther, J. Schmitt, P. Rehberger, 2012, The British journal of dermatology.

A systematic review of the outcomes reported in multimodal pain therapy for chronic pain

U. Kaiser, S. Deckert, F. Trautmann, 2016, European journal of pain.